TrademarkDir
HEIDELBERG IMMUNOTHERAPEUTIX
LIVE

Serial Number

79235348

Owner

Heidelberg ImmunoTherapeutics GmbH

Attorney

Catherine F. Hoffman

Filing Date

Mar 22, 2018

Add to watchlist:

No watchlists yet
+ Create New Watchlist
View on USPTO

HEIDELBERG IMMUNOTHERAPEUTIX Trademark

Serial Number: 79235348 • Registration: 5635349

HEIDELBERG IMMUNOTHERAPEUTIX is a trademark filed by Heidelberg ImmunoTherapeutics GmbH on March 22, 2018. The trademark is classified under Class 1 (Chemicals), Class 5 (Pharmaceuticals), Class 42 (Computer & Scientific). The application is currently registered and active.

Owner Contact Info

Heidelberg ImmunoTherapeutics GmbH

Max-Jarecki-Strasse 21 ngen Im

Entity Type: 27

Trademark Details

Filing Date

March 22, 2018

Registration Date

December 25, 2018

Published for Opposition

October 9, 2018

Cancellation Date

July 11, 2025

Goods & Services

Pharmaceutical, medical, and veterinary preparations, in particular for preventing and treating cancer and viral diseases; antibodies, antibody fragments and antibody derivatives for medical purposes, in particular for preventing and treating cancer and viral diseases; diagnostic reagents, in particular diagnostic antibodies, for medical purposes

Scientific, biological, medical and technological development and research in the field of biotechnology, chemistry, pharmacy and immunotherapy; research and development in the field of antibodies and immunology; scientific research for biotechnological, pharmaceutical and medical purposes, in particular in the field of cancerous diseases and viral diseases; laboratory services in the field of biotechnology, pharmacy and medicine; development of test methods, test reagents, in particular antibodies, and test kits for the scientific, biotechnological, pharmaceutical and medical sector; screening and selection of pharmaceutical active ingredients from biological and biotechnological preparations

Chemical, biochemical, biological and biotechnological preparations other than for medical purposes, in particular antibodies, antibody fragments and antibody-producing hybridomas for laboratories, clinics, diagnostics and analytics for scientific or research purposes; diagnostic reagents for scientific or research use; immunological reagents for industrial and scientific purposes

Filing History

TOTAL INVALIDATION OF REG EXT PROTECTION CREATED
Mar 11, 2026 INTR
NEW REPRESENTATIVE AT IB RECEIVED
Nov 14, 2025 NREP
CANCELLED SECTION 71
Jul 11, 2025 C71T
TEAS CHANGE OF CORRESPONDENCE RECEIVED
Apr 15, 2024 TCCA
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Apr 15, 2024 ARAA
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Apr 15, 2024 REAP
APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
Apr 15, 2024 CHAN
TEAS CHANGE OF OWNER ADDRESS RECEIVED
Apr 15, 2024 COAR
COURTESY REMINDER - SEC. 71 (6-YR) E-MAILED
Dec 25, 2023 REM3
CHANGE OF NAME/ADDRESS REC'D FROM IB
Mar 26, 2021 ADCH
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Jun 19, 2019 ARAA
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Jun 19, 2019 REAP
FINAL DECISION TRANSACTION PROCESSED BY IB
Apr 26, 2019 FINO
FINAL DISPOSITION NOTICE SENT TO IB
Apr 9, 2019 FICS
FINAL DISPOSITION PROCESSED
Apr 9, 2019 FIMP
FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
Mar 25, 2019 FICR
REGISTERED-PRINCIPAL REGISTER
Dec 25, 2018 R.PR
TEAS CHANGE OF CORRESPONDENCE RECEIVED
Dec 4, 2018 TCCA
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Oct 9, 2018 NPUB
PUBLISHED FOR OPPOSITION
Oct 9, 2018 PUBO
NOTIFICATION PROCESSED BY IB
Oct 7, 2018 GPNX
NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
Sep 19, 2018 OPNS
NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB
Sep 19, 2018 OP2R
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Sep 19, 2018 NONP
APPROVED FOR PUB - PRINCIPAL REGISTER
Aug 31, 2018 CNSA
TEAS/EMAIL CORRESPONDENCE ENTERED
Aug 29, 2018 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Aug 28, 2018 CRFA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
Aug 28, 2018 TROA
REFUSAL PROCESSED BY IB
Aug 11, 2018 RFNT
NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
Jul 26, 2018 RFCS
REFUSAL PROCESSED BY MPU
Jul 26, 2018 RFRR
NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
Jul 11, 2018 RFCR
NON-FINAL ACTION WRITTEN
Jul 10, 2018 CNRT
APPLICATION FILING RECEIPT MAILED
Jul 7, 2018 MAFR
ASSIGNED TO EXAMINER
Jul 3, 2018 DOCK
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Jul 3, 2018 NWOS
SN ASSIGNED FOR SECT 66A APPL FROM IB
Jun 28, 2018 REPR

Related Trademarks